View Published SNOMED CT Subset Metadata

QOF Prescribable angiotensin-II receptor antagonists

Subset Name :   
QOF Prescribable angiotensin-II receptor antagonists
Subset Original Id :   
Subset Type :   
Realm Concept

Refset FSN :   
Quality and Outcomes Framework general practice extraction - angiotensin II receptor antagonists prescribable within general practice simple reference set (foundation metadata concept)
Refset Id :   
Refset Type :   

Subset Description :
All VMPs and AMPs associated with the following VTMs: Amlodipine + Valsartan, Azilasartan, Candesartan, Eprosartan, Irbesartan, Irbesartan + Hydrochlorothiazide, Losartan, Losartan + Hydrochlorothiazide, Olmesartan, Olmesartan + Amlodipine, Olmesartan + Hydrochlorothiazide, Telmisartan, Telmisartan + Hydrochlorothiazide, Valsartan, Valsartan + Hydrochlorothiazide, Olmesartan + Amlodipine +Hydrochlorothiazide. The subset only includes VMPs and AMPs that have any of the following drug forms: Tablet, Capsule, Oral solution, Oral suspension, Modified release tablet, Modified release capsule and Powder. This subset, as currently published, supports the NHS England QOF business rules for 2016-2017. This subset may contain invalid concepts.


Subset Status :   
Subset Status Date :   
Mar 30, 2016
Owner (Organisation name) :   
NHS Digital

Purpose and Scope

Usage 1 :

Usage Type :    
Usage Description :    
Intended for secondary uses purposes. Management Information to support counts for establishing Quality and Outcomes Framework points used to determine Practice QOF payments. QOF Indicator Supported: Indicator CKD003: The percentage of patients on the Chronic Kidney Disease register with hypertension and proteinuria who are currently treated with an Angiotensin-Converting Enzyme Inhibitor (ACE-I) or angiotensin-II receptor antagonists (ARBs) NICE Guideline (where appropriate): These subsets are created using the XML format dm+d data and so within these subsets a small number of concepts are inactive (status 2 or 10) in the International Release. The origin of these inactive concepts is the native XML dm+d and they are now inactive in the new International Release due to natural movement and updating of the International Release content. Work is underway to update the dm+d concepts to the new International release identifiers; at this point this mismatch will be resolved. If using the dm+d in SNOMED CT format the International Release relationships will enable migration to the replacement concept. The subsets as published in the current release data are applicable to the QOF year 2016-2017.
Geographic Usage :    
Usage Category:    
 Quality Outcome Framework Prescribable

Scope :

Inclusion Criteria :   
Gender - not specified; Age group - any age; Sex - not specified
Subject Category :   
Prescribing; Chemicals and Drugs


Subset Release Category :   
UK Drug Extension
Language :   
Folder Name :   
File Name :   

Subset Licence Type :   
IHTSDO SNOMED CT® Licence; UKTC SNOMED CT® Licence; Open Government Licence

Metadata Version :   
Last Updated :   
Apr 30, 2020

Related Links

Subset download with descriptions :

UK Drug Extension releases